Lerozol® 2.5mg – 5 Pcs
Generic Name : Letrozole
Cytostatic Aromatase Inhibitor (Aromatase Inhibitor)
Manufacturer : Square Pharmaceuticals Ltd.
Indication: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer; Extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy ; First-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer; Advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Dosage & Administration: The recommended dose is one 2.5 mg tablet administered once a day, regardless to meals.
Preparation: Lerozol® Tablet: Box containing 1x5 tablets in blister pack.